Six CAR-T-cell therapies have been approved by the European Commission and the US FDA, and other T-cell therapies are being ...

"BrightPath and Cellistic partner for clinical trial advancements of CAR-T cell therapy" was originally created and published ...

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T ...

Craniopharyngiomas are brain tumors that negatively impact the hormonal function of the nearby pituitary. The tumor location ...

Larotrectinib for Newly Diagnosed Infantile Fibrosarcoma and Other Pediatric NTRK Fusion–Positive Solid Tumors (Children's Oncology Group ADVL1823) Sixteen patients were treated, with a median of four ...

This article explores some of the challenges in developing cell lines for therapeutics, such as cell line stability, and how ...

Discover the fascinating connection between space exploration and neuroscience. Learn how human brain cells develop ...

Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND", today announced a research ...

the 5th European CAR T-cell Meeting, Rotterdam, the Netherlands, February 9-11, 2023; the European Bone Marrow Transplant association conference, Paris, France, April 23-26, 2023; and the ISA ...

Food allergies affect millions of people worldwide, and flavonoids are promising natural compounds to help modulate the immune response and treat inflammation caused by these allergies. In a recent ...

Superior quality cytokines are crucial for reliable research results and the safe production of cancer cell therapies.

In April 2022, the U.S. Food and Drug Administration (FDA) granted the Regenerative Medicine Advanced Therapy (RMAT) designation to Autolus Therapeutics plc for its lead gene therapy, obecabatagene ...